A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

计划入组 1,650 人 · 首次发布于 2025 年 9 月 26 日

DurAVR™ THV EU-EFS

计划入组 15 人 · 首次发布于 2024 年 7 月 19 日

DurAVR™ THV System: EMBARK Study

计划入组 150 人 · 首次发布于 2022 年 1 月 10 日

ThV-01

ThV-02

X-Synergy®

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

Clinical Hospital Dubrava

Anteris Technologies Initiates U.S. Enrollment in PARADIGM Trial for Novel Biomimetic Heart Valve

Anteris Technologies Receives European Regulatory Clearance for DurAVR Global Pivotal Trial in Aortic Stenosis

Anteris Technologies Raises $200 Million to Advance Aortic Stenosis Treatment with Strategic Medtronic Partnership